Author Archive for: panglobal

New research reveals over 3 million children died globally from AMR-related infections in 2022, with particular concerns about increasing use of critical antibiotic classes.

Safety concerns prompt Pfizer to terminate development of once-daily oral GLP-1 receptor agonist for weight management, despite promising pharmacokinetic data from recent dose-optimisation studies.

Bio-Rad Laboratories has achieved a significant regulatory milestone with EU Quality Management Systems certification under the In Vitro Diagnostic Regulation (IVDR), enabling CE marking for 40 infectious disease molecular quality control products from their Exact Diagnostics brand.

Cambridge-based 4basebio has received Good Manufacturing Practice certification from the UK’s Medicines and Healthcare products Regulatory Agency, enabling the company to supply GMP-grade synthetic DNA for clinical applications in cell and gene therapy development.